Table 1.

Baseline characteristics of the patients

Number of patients	n = 27 (range of %)
Median age (range)	48 (19 – 67)
Male sex (percentage)	14 (52%)
Baseline disease
Acute leukemia	9 (33%)
Chronic leukemia	2 (7%)
Lymphoma	13 (48%)
Myeloproliferative disease	3 (11%)
Clinical outcome
Completed study	13 (48%)
Death prior to study completion	13 (48%)
Lost to follow up	1 (4%)
Acute GVHD	7 (26%)
Chronic GVHD	2 (7%)
Median days to neutrophil engraftment	21 (13 – 70)
Median days to platelet engraftment	42 (25 – 162)
Positive anti-BKV IgM antibody	3 (13%)